GI
CGON icon

GAMMA Investing’s CG Oncology CGON Stock Holding History

GAMMA Investing’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$76.6K Buy
1,081
+350
+48% +$25.7K ﹤0.01% 2073
2026
Q2 		$51.9K Buy
731
+70
+11% +$4.58K ﹤0.01% 2271
2026
Q1 		$44.7K Buy
661
+150
+29% +$8.5K ﹤0.01% 2250
2025
Q4 		$21.2K Buy
511
+20
+4% +$828 ﹤0.01% 2579
2025
Q3 		$19.8K Sell
491
-40
-8% -$1.16K ﹤0.01% 2520
2025
Q2 		$13.8K Buy
531
+437
+465% +$10.5K ﹤0.01% 2650
2025
Q1 		$2.3K Sell
94
-106
-53% -$2.98K ﹤0.01% 3372
2024
Q4 		$5.74K Buy
200
+94
+89% +$3.22K ﹤0.01% 2859
2024
Q3 		$4K Buy
+106
New +$3.72K ﹤0.01% 2833

Other funds holding CGON

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

GAMMA Investing's CGON Position: Q3 2026 in Review

GAMMA Investing increased its CG Oncology (CGON) stake by 48% in Q3 2026, buying an estimated $25.7K and bringing the position to 1,081 shares worth $76.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

GAMMA Investing first reported a position in CGON in Q3 2024 and has held it in 9 quarters since. 8 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • GAMMA Investing held 1,081 shares of CG Oncology worth $76.6K as of Q3 2026.
  • GAMMA Investing bought 350 CG Oncology shares in Q3 2026, an estimated $25.7K.
  • CG Oncology made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2073 holding.
  • GAMMA Investing first reported a position in CG Oncology in Q3 2024 and has held it in 9 quarters since.
  • 8 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.